table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID-19 mild to moderateCOVID-19 severe or critically
COVID 19 hospitalizedCOVID-19 mild to moderateCOVID-19 severe or critically
lopinavir/ritonavir SOLIDARITY ... Nojomi Chen_lopi_rito Ader ... RECOVERY ELACOI ... REMAP-CAP ... Cao

1 studies excluded by filtering options 2

5210 Ye et al., 2020 2990excludednot a RCTrisk of bias not avaialble

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons